| Literature DB >> 34209394 |
Douglas Souza Oliveira1,2,3, Jean Gabriel de Souza1, Miryam Paola Alvarez-Flores1,2, Priscila S Cunegundes1,2,3, Carlos DeOcesano-Pereira1,2, Aline Maia Lobba1,2, Renata N Gomes1,2, Ana Marisa Chudzinski-Tavassi1,2.
Abstract
Envenomation caused by contact with Lonomia obliqua bristles is characterized by pain, an intense systemic proinflammatory reaction and disturbances in the coagulation cascade that can cause severe clinical manifestations and death. However, the role of immune system components in these effects is still poorly understood. In this study, we evaluated the cytotoxic effect of L. obliqua venom on THP-1-derived macrophages and its ability to modulate inflammatory markers, as well as the cytokine and chemokine release profile. Our results show that L. obliqua venom is able to directly exert a potent pro-inflammatory reaction in macrophages, characterized by the activation of the NF-κB transcription factor pathway, the expression of CD80 and CD83, and the release of pro-inflammatory mediators such as TNF-α, IL-1β, IL-6, IL-8 and CXCL10. These results suggest that macrophages can play an important role during the orchestration of the inflammatory response present in envenomation caused by Lonomia obliqua caterpillars.Entities:
Keywords: Inflammation; Lonomia obliqua; macrophage activation
Mesh:
Substances:
Year: 2021 PMID: 34209394 PMCID: PMC8309978 DOI: 10.3390/toxins13070462
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Figure 1Effect of LOCBE on macrophage viability. (A) Cellular viability was measured by MTT assay after 24 h of treatment with three different concentrations of LOCBE. Hydrogen peroxide (H2O2) was used as the positive control. (B) Supernatants from the MTT assay were used to evaluate LDH release as a cytotoxicity marker. All data represent the mean ± S.E.M. Significant differences between the control and treatments were evaluated using Student’s t-test. (n = 3, ** p < 0.01; **** p < 0.0001 vs. control 100%).
Figure 2Effect of LOCBE on NF-κB pathway activation. (A) Representative images of NF-κB nuclear translocation verified by high content imaging after 30 min of THP1-derived macrophages treatment with LOCBE. Macrophages were fixed and immunostained for NF-κB (p65) antibody and secondary AlexaFluor-647 and the nuclei (blue) were stained with Hoechst 33342 (5 µM). (B) NF-κB translocation was calculated by measuring the ratio of fluorescent intensity of the protein in the nucleus and cytoplasm region. Data are expressed as the percentage of positive cells. Negative cells mainly displayed cytoplasmatic staining of NF-κB (red). Stimulation with LPS or LOCBE caused translocation of NF-κB to the nucleus. Data represent the mean ± S.E.M. Significant differences between the control and treatments were performed by Student’s t-test (n = 3, *** p < 0.001).
Figure 3LOCBE upregulates gene expression of inflammatory modulators. mRNA expression levels of transcriptional factors genes related to the regulation of the inflammatory response (STAT1, STAT3, IRF4, IRF5, NF-κB) (A) and proinflammatory cytokine genes (TNF-α, IL-1β, IL-6 and IL-8) (B) in macrophage after 6 h treatment with 5 µg/mL LOCBE. RPL17A and ACTB genes were used as housekeeping genes. Data are shown as the mean ± S.E.M. of fold change (2−(ΔΔCt)) compared to the control group without treatment (n = 3, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, Student t-test.).
Figure 4Cytokine secretion profile in LOCBE-treated macrophage. Cells were treated with 5 μg/mL LOCBE and cytokine release was evaluated after 6 h (A) and 24 h (B) by Millipore Multiplex assay. Data are shown as mean ± S.E.M. in pg/mL. Significance of the differences were evaluated with t Student test (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001).
Macrophage upon treatment with LOCBE chemokine release profile.
| Analyte (pg/mL) | Control | LPS | LOCBE | |||
|---|---|---|---|---|---|---|
| 6 h | 24 h | 6 h | 24 h | 6 h | 24 h | |
|
| 219.8 ± 101 | 2670 ± 200.3 | 13,831 ± 2379 ** | 16,729 ± 503.3 **** | 11,888 ± 1362 ** | 17,275 ± 107.6 **** |
|
| 17.53 ± 1.2 | 114.1 ± 23.1 | 69.20 ± 15.7 * | 2405 ± 612.6 * | 36.23 ± 12.5 | 2283 ± 263.5 *** |
|
| 5810 ± 1826 | 455.6 ± 51.9 | 8678 ± 341.5 | 8448 ± 217.3 **** | 7399 ± 979.9 | 6015 ± 1471 * |
|
| 5587 ± 1329 | 450.9 ± 110 | 7887 ± 312.8 | 8108 ± 92.5 **** | 7294 ± 732 | 8200↑ |
|
| 5802 ± 1462 | 5161 ± 784.3 | 8643↑ | 8643↑ | 8090 ± 553.5 | 8643↑ |
Chemokine secretion profile in Lonomia obliqua bristle extract-treated macrophage. Cells were treated with 5 μg/mL of LOCBE for 6 and 24 h and evaluated for the release of CXCL10, CCL22, CCL2, CCL3 and CCL4 by Multiplex assay. Data are represented in pg/mL with mean ± SEM. Values above the detection limit of the assay are indicated by a vertical arrow (↑). Significant differences in relation to untreated control were evaluated using Student’s t test (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001).
Figure 5LOCBE increases the expression of macrophage activation markers. Macrophages were treated 24 h with LOCBE at 5 μg/mL, then stained with specific antibodies for CD80-BB515 (A) and CD83-APC (B) followed by Imaging flow Cytometry analysis. Data are shown as the mean of Median of Fluorescence Intensity (MFI) ± S.E.M. (C) Representative images of CD80 (green) and CD83 (red) staining. (** p < 0.01, *** p < 0.001).